Time to Invest in L...
Health Care: Drugs
Alnylam Pharmaceuticals Inc. (ALNY: NASDAQ)
$28.98 0.92 | 3.28%
05/24/13 - 04:00 PM ET
Portfolios with ALNY
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- UserThe #1 Growth Fund To Make ...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- Userkite
- UserPART 6 JPMorgan 28th Annual...
- UserWilliam T Blanchard - Medical
- ContributorHealthcare Short Squeezes f...
- UserS.A.Chili
Latest ALNY Headlines from TheStreet
- Cramer's Top Stock Picks: CAT CAG MHR ISS ALNY SGMO KIM 04.04.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Risk vs. Reward 04.03.13 | 08:04 pm
- 'Mad Money' Lightning Round: I Like Bank of America 02.23.13 | 06:02 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 02.22.13 | 08:02 pm
- J.P. Morgan Healthcare Confab Live Blog Day Three 01.09.13 | 10:01 am
- Alnylam Pharmaceuticals' CEO Presents At Morgan Stanley Global Healthcare Conference (Transcript) 09.12.12 | 10:09 am
- Alnylam Pharmaceuticals CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.06.12 | 10:08 pm
- 5 Stocks Insiders Love Right Now 02.24.12 | 12:02 pm
- 8 Stocks Rising on Huge Volume 02.15.12 | 02:02 pm
- 'Mad Money Lightning Round': Stay Long Sandridge 01.03.12 | 07:01 pm
Press Releases for ALNY
- Alnylam Initiates Phase I Clinical Study For ALN-TTRsc, A Subcutaneously Administered RNAi Therapeutic Targeting Transthyretin (TTR) For The Treatment Of TTR-Mediated Amyloidosis (ATTR) - Business Wire 03.18.13 | 08:03 am
- Alnylam To Webcast Presentation At Barclays Global Healthcare Conference - Business Wire 03.05.13 | 04:03 pm
- Alnylam To Webcast Presentation At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.26.13 | 04:02 pm
- Corporate Leaders Receive Thirteenth Annual Emerald Asset Management “E-3 Awards” - Business Wire 02.11.13 | 10:02 am
- Alnylam Pharmaceuticals Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 02.07.13 | 04:02 pm
- Alnylam To Webcast Presentation At Upcoming Investor Conferences - Business Wire 02.05.13 | 04:02 pm
- Over 25 Companies To Present At Emerald Groundhog Day Investment Forum - Business Wire 02.05.13 | 10:02 am
- The Medicines Company And Alnylam Form Strategic Alliance To Develop And Commercialize RNAi Therapeutics Targeting PCSK9 For The Treatment Of Hypercholesterolemia - Business Wire 02.04.13 | 06:02 am
- Alnylam To Webcast Conference Call Discussing Fourth Quarter And 2012 Financial Results - Business Wire 01.31.13 | 04:01 pm
- Alnylam And Collaborators Publish Results From Phase I Clinical Trial And Extension Study With ALN-VSP, An RNAi Therapeutic For The Treatment Of Liver Cancer - Business Wire 01.30.13 | 08:01 am
Partner Headlines for ALNY
- Alnylam-Tekmira Settle Up - Analyst Blog - Zacks 11.19.12 | 07:11 pm
- Revenues Decline at Alnylam - Analyst Blog - Zacks 11.07.12 | 09:11 am
- Isis Pharmaceuticals To Receive $1.1 Million From Alnylam - Benzinga 10.23.12 | 01:10 pm
- Alnylam-ISIS Venture Prices IPO - Analyst Blog - Zacks 10.05.12 | 06:10 pm
- Alnylam Presents Data on ALN-RSV01 - Analyst Blog - NASDAQ 09.06.12 | 11:09 pm
- Alnylam Presents Data on ALN-RSV01 - Analyst Blog - Zacks 09.06.12 | 07:09 pm
- Alnylam & Monsanto Collaborate - Analyst Blog - NASDAQ 08.29.12 | 09:08 pm
- Alnylam/Isis's Regulus to Go Public - Analyst Blog - NASDAQ 08.22.12 | 11:08 pm
- Alnylam/Isis's Regulus to Go Public - Analyst Blog - Zacks 08.22.12 | 07:08 pm
- Biogen Inks Deal with Regulus - Analyst Blog - NASDAQ 08.16.12 | 10:08 pm
